Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314

NCT04871646 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

586

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: CKD-314+SOC
DRUG: CKD-314 Placebo+SOC

Sponsor

Chong Kun Dang Pharmaceutical